Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
3.540
-0.360 (-9.23%)
At close: Apr 2, 2026, 4:00 PM EDT
3.550
+0.010 (0.28%)
After-hours: Apr 2, 2026, 7:35 PM EDT
Ironwood Pharmaceuticals Employees
Ironwood Pharmaceuticals had 100 employees as of December 31, 2025. The number of employees decreased by 153 or -60.47% compared to the previous year.
Employees
100
Change (1Y)
-153
Growth (1Y)
-60.47%
Revenue / Employee
$2,961,510
Profits / Employee
$240,170
Market Cap
577.23M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 100 | -153 | -60.47% |
| Dec 31, 2024 | 253 | -14 | -5.24% |
| Dec 31, 2023 | 267 | 48 | 21.92% |
| Dec 31, 2022 | 219 | 0 | - |
| Dec 31, 2021 | 219 | -13 | -5.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tilray Brands | 2,842 |
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Pacira BioSciences | 829 |
| Kamada | 462 |
| Esperion Therapeutics | 294 |
| Akebia Therapeutics | 194 |
| Aquestive Therapeutics | 147 |
IRWD News
- 4 weeks ago - Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference - Business Wire
- 5 weeks ago - Ironwood Pharmaceuticals: Downgrading On Pipeline Setback And Extended Timeline For Apraglutide - Seeking Alpha
- 5 weeks ago - Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook - Business Wire
- 6 weeks ago - Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call - Business Wire
- 3 months ago - Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance - Business Wire
- 4 months ago - Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025 - Seeking Alpha
- 5 months ago - Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance - Business Wire